We are building an exciting new breed bioscience company through the combination of early-stage novel science and long-term shareholder capital.
Cambridge Science Corporation (CSC) launched in 2018 with the mission of improving patient lives through the acceleration of translational research and creating long-term value for our shareholders. We are pursuing internal drug development programs and we launch, finance, and manage biotech companies commercializing novel technologies developed in the top labs at the world’s premier research institutions. Our primary goals are to help patients by focusing on opportunities that address large unmet medical needs and to create long-term value for our shareholders. Our research and development capital allocation process prioritizes three characteristics of successful biotech companies in order: people, science, and intellectual property.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2017
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Cambridge Science founded?
Cambridge Science was founded in 2017.
What industry is Cambridge Science in?
Cambridge Science operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cambridge Science based?
Cambridge Science is headquartered in Cambridge, United States.
Find investors for your startup like Cambridge Science
Gritt sends AI-personalised outreach to each investor — from your Gmail
